Simon Bailey
Chief Operating Officer & President - Research & Development Unnatural Products Inc.
Seminars
Wednesday 15th July 2026
Panel Discussion: Optimizing Next-Generation Delivery From Molecular Precision to Functional Resilience Improving Tissue Health Across the Lifespan
12:30 pm
- Standardizing tissue-specific permeability and “molecular-reach” as a core regulatory endpoint to move beyond systemic bioavailability as the “gold standard” for pediatric and geriatric success, leading to a more nuanced and accurate reflection of metabolic health across all ages
- Evaluating the ethics and logistics of long-term “follow-on” studies to track the 10-year impact of incretins on muscle progenitor cell health and mitochondrial function, building the robust safety database required for universal pediatric approval
- Integrating objective metabolic-reserve metrics regarding “muscular-force” and “mitochondrial-efficiency” to capture the human impact of treatment, ensuring that drug development remains focused on functional longevity rather than just cosmetic weight loss
